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DAILY UNM GLOBAL HEALTH COVID-19 BRIEFING
April 16, 2020

Executive Summary
Daily NM recap. Public Catholic masses resume. Chaplains stand down. Food delivered to tribal communities. Governors
order face coverings use. Campfires restricted. NY hospitalizations fall. Nursing home probe in NJ. GOP call WHO Chief
resignation. Africa cases up 51% and deaths up 60%. Sub-Saharan Africa prediction. Resurgence in Japan. UK conditions
to reopen. France deaths up. UNMH protests over PPE. Med center financial stress. Hospitals bailout insufficient. 55%
US healthcare worker cases hospital spread. Cruise ship transmission. Essential contact tracing. JAMA editors discuss
policy. Guideline updates: treatment, emergency dep, ophthalmology, cath lab, telemedicine, liver disease, caregiver,
health care facilities, FEMA, homeless services. Calcium channel blocker reduces fatality. Interferon lambda treatment.
No benefit for lopinavir/ritonavir or arbidol in RCT. Donate plasma. Mixed results for antivirals on clearance. 37 new
trials. Population-scale testing proposed. New rapid assay. Serology + RT-PCR needed. Hemoglobin monitoring. Coinfection of SARS-CoV-2. Urine glucose and proteinuria predict severity. Use damp cloth covers.

Our continuously curated practice guidelines in the context of COVID-19 can be found here.
You may submit content for future briefings here.

NM Highlights
•

8 new deaths and 116 additional positive COVID-19 cases reported in NM
The total positive cases and total deaths in the state are 1,597 and 44 respectively. As of today, the state has done 34,488
tests, there are 90 individuals hospitalized for COVID-19, and 353 COVID-19 cases have recovered. New NMDOH portal
featuring epidemiologic breakdown of cases

•

Catholic bishop of Las Cruces will resume public masses in compliance with social distancing orders
The bishop, Peter Baldacchino of Las Cruces, announced Wednesday afternoon that his diocese will resume public masses,
making it the first in the United States to do so. Baldacchino said he will remain in compliance with social distancing orders
from New Mexico Gov. Michelle Lujan Grisham and restrict attendance to five people at all masses within churches, including
the celebrant. He also recommended that priests celebrate masses outside or as drive-in services.

•

Chaplains at UNMH exposed to Coronavirus, APD chaplains standing down
Albuquerque Police’s Chaplain Unit is standing down after learning chaplains at the University of New Mexico Hospital have
tested positive for the coronavirus. A spokesperson from UNMH says some of their chaplains were asked to quarantine but
would not confirm how many tested positive or how many are still working. Only 9/17 of APD chaplains are still volunteering
their time specifically to police officer. Many of the chaplains are older than 60 and are afraid for their own health.

•

Incredible success in partnering with the Navajo Nation & pueblos to deliver food to tribal communities
Over 80,000 lbs. of rice, beans, potatoes, watermelons, apples, and onions have been delivered to the Navajo Nation. Food
for nearly 4,000 tribal citizens has been delivered to the pueblos of San Felipe, Zia, and Isleta. 4,000 food boxes have been
delivered to tribal senior centers.

US Highlights
•

Governors across the country order use of masks in public as people emerge from isolation
As the president speaks of reopening economy, state governments are cautiously preparing constituents as lockdowns
unwind. Some states are ordering the use of face masks when in public, others are only recommending.

•

New Mexico National Forests restrict campfires during COVID-19 pandemic

The U.S. Department of Agriculture's Forest Service Southwest Region, which includes Lincoln National Forest, enacted the
measure effective April 15 until further notice, according to a news release. The Southwest Region includes all five New
Mexico National Forests as well as six sites in Arizona.

•

Hospitalization for coronavirus falls in New York, New Jersey launches nursing home probe
The number of people hospitalized for the coronavirus and related deaths in New York fell to their lowest levels in more than
a week, adding to evidence the hardest-hit state was controlling its spread, Governor Andrew Cuomo said on Thursday
(4/16). New Jersey Governor Phil Murphy ordered a review of long-term care facilities across the state after learning that one
nursing home had piled up dead bodies in a makeshift morgue.

•

U.S. Republicans back Trump and call for WHO chief to resign
Seventeen of Trump’s fellow Republicans on the House of Representatives Foreign Affairs Committee called on President
Donald Trump on Thursday to withhold payments to the World Health Organization until its director general resigns.

•

FDA cautions slower drug review activity due to reallocation of staff to COVID-19
The US Food & Drug Administration said it may not be able to sustain its current level of timely reviews and approvals of
marketing applications due to shortage of staff. Many staff are allocated to the coronavirus crisis but working to ensure that
the drug programs continue to see minimal interruptions during this time. If there was an increase in drug shortages and
supply disruptions, the FDA will be ready to reprioritize its work.

International Highlights
•

WHO releases weekly Africa situation report: 10,759 cases and 520 deaths
There has been a 51% increase in the number of cases and a 60% increase in the number of deaths reported in the WHO
African Region over the past one week. By 14th April 2020, a cumulative total of 10,759 confirmed COVID-19 cases with 520
deaths (case fatality ratio CFR:4.8%) have been reported across the 45 affected countries in the region.

•

The anticipated COVID-19 crisis in Sub-Saharan Africa: timely investments are needed
Tropical Medicine and Health Letter to the Editor: The authors predict the African crisis to be greater than it is in other
regions due to its weak health systems. African governments and WHO should invest immediately in preparedness for the
worst-case scenario given Africa has high volume of air traffic with China.

•

Hokkaido, Japan declares state of emergency for second time due to resurgence of cases
The first state of emergency declaration was lifted March 19, now 26 days later, it is reinstated. A second wave has come,
with 135 new cases confirmed last week. Japanese professor warns that local containment may seem simple, but
transmission will continue as long as people continue to move around.

•

Five conditions which must be met before UK eases lockdown
Foreign Secretary Dominic Raab extended Britain’s lockdown for three more weeks and set out five conditions that must be
satisfied before the government will ease far-reaching restrictions.

•

Coronavirus death toll up again in France but number of hospitalized people declined
France registered 753 more deaths from coronavirus infections on Thursday, bringing the total to 17,920, the fourth-highest
tally in the world, but the number of people in hospital has declined for a second day running.

Economics, Workforce, Supply Chain, PPE Highlights
•

UNMH staff protest lack of PPE and other concerns
Daily Lobo reports University of New Mexico Hospital employees and allies hold protest in front of hospital Wednesday.
Grievances include: only nurses and doctors get N95 masks with staff getting surgical masks, concerns about N95 reuse, and
14-day mandated quarantines that come out of paid time off or sick leave.

•

Mitigating academic medical centers financial stress: policy options
Academic Medicine: this Invited Commentary reviews existing data on academic medical centers debt levels; summarizes

relief provided in the Coronavirus Aid, Relief, and Economic Security Act; and suggests policy options to help mitigate risk.

•

Both urban and rural hospitals raise concerns that federal bailout falls short
New York received roughly $1.9 billion from the first round of federal support, or $11,600 per reported COVID-19 patient and
states with fewer cases up to 16 more per patient because of the funding approach used. Hospitals need the money to pay
for overtime, and for PPE among other things. Rural hospitals are concerned that they won't be effectively represented for
the next round of funding later this week which is supposed to help the hotspots of covid outbreak.

Epidemiology Highlights
•

CDC report on 9,282 US healthcare worker cases: 55% of infection appears hospital spread
CDC MMWR report: Of 9,282 U.S. COVID-19 cases reported among health care personnel (HCP): median age 42, 73%
female, reflecting distributions in health workforce. 55% of HCP patients reported no contact with COVID outside health care
context. 27 deaths occurred; rates were highest among those 65 and over.

•

Cruise ship study suggests no central air conditioning transmission
MedRxiv preprint: Looking at timing of positive testing and quarantines, modeling of transmission appeared to happen prior
to quarantine among those in the same staterooms and upon disembarking. Authors infer that the ship central air
conditioning system did not play a role, and thus long-range airborne route was absent in this outbreak.

•

Why contact tracing is essential to stop the coronavirus from spreading
Contact tracing is a process designed to halt the chain of transmission of an infectious pathogen — like the coronavirus —
and slow community spread. The whole point of this process is to make sure that people who have the virus are separated
from those who don't. That includes the original case being isolated, and the contacts who might be incubating the disease.

•

Contact tracing helped reduce viral infections in Iceland
Containment efforts through contact tracing and population screening has shown reduced incidence of infection in Iceland.

Healthcare Policy Recommendations
•

JAMA Health Forum editors talk about changes in U.S. health care policy
Youtube video: JAMA Health Forum editors John Ayanian, MD, MPP, and Melinda Buntin, PhD discuss changes in U.S. health
care and health policy driven by the pandemic. Recorded on April 16, 2020.

Practice Guidelines
•

Society of Infectious Diseases Pharmacists review on COVID-19 treatment
The Society of Infectious Diseases Pharmacists summarize the current evidence as of March 18, 2020 to provide guidance on
potential COVID-19 treatment options.

•

SARS-CoV-2: an overview for emergency clinicians
A review analyzes information from worldwide research and experience on the epidemiology, prevention, and treatment of
COVID-19, and offers links to the most reliable and trustworthy resources to help equip healthcare professionals in managing
this public health challenge.

•

Chinese experience against SARS-CoV-2 in ophthalmology
Based on 33 articles published by Chinese scholars, guidelines and clinical practice experience in domestic hospitals, the
authors have summarized the Chinese experience to protect ophthalmologists and patients.

•

Catheterization laboratory priorities during COVID-19: guidelines and recommendations
European Heart Journal offers guidelines on how to manage a catherization lab during the pandemic to complement earlier
guidelines from 1) Journal of the American College of Cardiology; 2) National Institute for Heatlh and Care Excellence.

•

Management of liver disease during the COVID-19

European Association for the Study of the Liver (EASL) and the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) issued a position paper, providing recommendations for clinicians caring for patients with liver diseases
during the current pandemic.

•

CDC launches new podcast on caregivers and unsafe caregiving practices
Caregivers provide crucial support for their care recipient and the health care system but may be compromising their own
health in the process and many are providing "unsafe caregiving".

•

Best practices for healthcare facilities
The FEMA Federal Healthcare Resilience Task Force published the "COVID-19 Hospital Resource Package", which is intended
to provide publicly accessible guidance and tools to better enable the healthcare response to COVID-19. The document
provides guidance on surge planning for the emergency department, critical care, and mortuary services; crisis standards of
care; staffing surge and resilience; workforce protection; regulatory concerns; PPE and healthcare supply chains; and
telemedicine to support US health systems’ efforts to combat the growing epidemic.

•

CDC guidelines for healthcare professionals
CDC offers trainings on clinical care and infection control, personal protective equipment, non-pharmaceutical infections, and
emergency preparedness and response specific to COVID-19 to Healthcare professionals.

•

Interim guidance for homeless service providers to plan and respond to COVID-19
CDC has developed recommendations for homeless service providers, including overnight emergency shelters, day shelters,
and meal service providers and how to protect their staff, clients, and guests.

•

Monitor hemoglobin in COVID-19 patients: evidence from a meta-analysis
Meta-analysis of 4 studies show in 3/4 that hemoglobin was significantly lower in COVID patients with severe disease than
with milder forms, yielding a weighted mean difference of −7.1 g/L; (95% CI, −8.3 to−5.9 g/L). Advise initial assessment and
longitudinal monitoring of hemoglobin, and urge research to assess whether transfusion support may reduce morbidity and
mortality.

Drugs, Vaccines, Therapies, Clinical Trials
•

Calcium channel blocker amlodipine is associated with reduced case fatality
MedRxiv preprint: 4 calcium channel blocker (CCB) antihypertensives showed in vitro inhibition of viral replication. In this
retrospective study of hospitalized hypertensive patients (n=90) with 15 fatalities, amlodipine besylate (Norvasc) was
compared to no treatment and other antihypertensives. Case fatality rate (CFR) was decreased from 26.1% (12/46) in nonamlodipine treated group to 6.8% (3/44) in amlodipine treated group (P = 0.022). Kaplan-Meier analysis demonstrated
reduced risk of death in amlodipine group, in comparison with non-amlodipine one (P = 0.033, log-rank test). Other CCBs
(n=4) did not have enough sample size for comparison. In vitro studies also suggest synergism of chloroquine and CCBs.

•

A viewpoint on the interferon lambda treatment option, pros and cons
This Viewpoint presents an opinion on the benefits and potential limitations of using IFN-lambda to prevent, limit, and treat
COVID-19.

•

Neither lopinavir/ritonavir or arbidol provided virologic or clinical benefit in an RCT
In a randomized controlled trial (partially blinded) 34 patients with mild/moderate disease were assigned to LPV/r, 35 to
arbidol and 17 had no antiviral medication. There were no significant differences in duration of viral shedding, rates of
symptoms resolution or improvement of chest CT, or rates of progression to severe states.

•

FDA encourages recovered patients to donate plasma for development of blood-related therapies
The FDA is providing an update on convalescent plasma and encouraging those who have recovered from COVID-19 to
donate plasma to help others fight this disease.

•

Antivirals do not reduce time of viral clearance, lopinavir/ritonavir delayed viral clearance
MedRxiv preprint: Guangzhou study examined 284 consecutive COVID-19 cases. 280 patients achieved viral RNA clearance

with a median length of 12 days (IQR: 8-16) after onset of illness. 66.1% of them had viral RNA cleared within 14 days, and
89.3% within 21 days. Older age, severity of disease, time lag from illness onset to hospital admission, fever, and
corticosteroid use were associated with delayed clearance of viral RNA. None of the antiviral regimens (chloroquine,
oseltamivir, arbidol, and lopinavir/ritonavir) improved viral RNA clearance. Lopinavir/ritonavir was associated with delayed
clearance of viral RNA after adjusting for confounders.

•

37 new COVID-19 trials registered today at clinicaltrials.gov
Treatment trials: Plasma Rich Antibodies. Management with Favipiravir. Automated Serologic Testing. Transmissibility and
Viral Load via Oral Secretions. Convalescent Plasma. Hydroxychloroquine and Azithromycin ambulatory patients. Longitudinal
Energy Expenditure and Metabolic Effects. Allogeneic HB-adMSCs Immune Support. Evaluating Immune Response.
Clazakizumab (Anti-IL- 6 Monoclonal) vs. Placebo. Subcutaneous Canakinumab Pneumonia. Defibotidefor Respiratory Distress
and Cytokine Storm. Nitazoxanide Efficacy and Safety for Hospitalized Patients. Immune and Inflammatory Response
Allogeneic Haematopoietic Stem Cell Transplantation (SCT). HCQ Prophylaxis HCP. Activity and Safety Oral Selinexor Severe
Disease. Fleming [FMTVDM] Directed Treatment. Safety and Efficacy HB-adMSCs. Ruxolitinib Plus Simvastatin Respiratory
Failure. Triiodothyronine Critically Ill Patients. BCG Vaccine for HCP. Hydrocortisone and Severe Hypoxia. Dexmedetomidine
Light to Moderate Sedation Palliative Situation. Ultraprotective Ventilation w/o Extracorporeal Circulation Pneumonia. ICU
Trial Critical Ill. Antibody Self-testing Virtual Point-of-care. Qatar Prospective RCT Therapy. Resilience During Epidemic. Birth
Experience. Emotional Burden of HCP. Symptom, Exposure and Immune Response Registry. Virus Outbreak Affects
Antimicrobial Resistance LMICs. Using Mesenchymal Stromal Cells. Early Extubation Acute Hypoxemic Respiratory Failure. At
time of writing, a total of 611 were active, 28 completed, and 3 posted results.

Other Science
•

Viral load as function of antiviral potency and timing of Tx initiation -- early Tx essential
Model shows expected viral reduction as function of drug efficacy and how early or late treatment starts. Potent drug
therapy ideal when presymptomatic, with less efficacy the longer one waits. Immunotherapy ineffective if started prior to
peak viral load. Viral load peaks just as symptoms appear. This highlights the need for earlier detection and contact tracing.
Model suggests clinical trial endpoints based on reducing viral load may fail when agents introduced late.

•

Enabling population-scale COVID-19 diagnostics using a compressed barcode space
In a testing protocol proposed by researchers from Broad Institute, every sample being tested for SARS-CoV-2 would be
tagged with a unique DNA sequence that would serve as a biological barcode. High-speed sequencing instruments common
in research laboratories around the world could then be used to analyze as many as 100,000 DNA samples at one time.

•

A new rapid and accurate assay developed: a better alternative to PCR
A rapid (<40 min), easy-to-implement and accurate CRISPR–Cas12-based lateral flow assay is developed for detection of
SARS-CoV-2 from respiratory swab RNA extracts. It was validated on patients in the US, including 36 patients with COVID-19
and 42 patients with other viral respiratory infections. The assay provides a visual and faster alternative to the US CDC SARSCoV-2 real-time RT–PCR assay, with 95% positive predictive agreement and 100% negative predictive agreement.

•

Serology testing complements RT-PCR for better diagostic coverage
The results of a comprehensive analysis of a family cluster study emphasized the significance of serology testing to assist
timely diagnosis of SARS-CoV-2 infections, especially for COVID-19 close contacts screening. A family cluster of SARS-CoV-2
was identified and analyzed based on clinical characteristics, chest CT, SARS-CoV-2 molecular detection, and serology. Five of
6 family members tested positive for SARS-CoV -2-specific immunoglobin serology. However, molecular assays only detected
2 of these 5 patients. Two patients were diagnosed with COVID-19, two were suspected of COVID-19, and two were
considered close contacts. Repeated RT-PCR assays and serology testing should be performed for patients who are IgM
positive, while dynamic change of SARS-CoV-2-specific IgG from negative to positive supporting the COVID-19 diagnosis.

•

Hemoglobin may be decreased in patients with severe disease
Meta-analysis of 4 studies show in 3/4 that the hemoglobin value was significantly lower in COVID-19 patients with severe
disease than in those with milder forms, yielding a WMD of −7.1 g/L; (95% CI, −8.3 to−5.9 g/L). Initial assessment and

longitudinal monitoring of hemoglobin values is advised. Subsequent studies are urged to assess whether transfusion support
may help to reduce morbidity and mortality.

•

Rates of co-infection SARS-CoV-2 and other respiratory pathogen more common than reported prior
A total of 1217 specimens were tested for SARS-CoV-2 and other respiratory pathogens from 1206 unique patients. None of
the differences in rates of non–SARS-CoV-2 pathogens between specimens positive and negative for SARS-CoV-2 were
statistically significant. The most common co-infections were rhinovirus/enterovirus (6.9%), respiratory syncytial virus (5.2%),
and non–SARS-CoV-2 Coronaviridae (4.3%). These results suggest higher rates of co-infection between SARS-CoV-2 and other
respiratory pathogens than previously reported.

•

Urine glucose and proteinuria are predictors of COVID-19 severity
119 COVID-19 patient and 45 control Wuhan prospective study shows higher urine pH, and higher urine glucose and
proteinuria (PRO) in the severe and critical groups versus moderate. Versus controls, COVID-19 patients have statistically
significantly elevated occult blood, and PRO, lowered urine specific gravity.

•

Laser tests show effectiveness of damp cloth mouth covers to reduce COVID exposures
An experiment visualizing speech-generated, oral fluid droplets with laser light scattering demonstrated that droplets
generated through speech might have the potential to spread the COVID virus, particularly with specific speech sounds and
with loud voices. When using a wet cloth in front of the mouth, droplet spread was reduced near background levels. More
work is needed to demonstrate whether cloth coverings will effectively protect people from COVID exposures and whether
wetting the cloth is crucial to make covers more effective.
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